Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2008 Filed Jun 2, 2008 20:42 UTC GrantStock Option · Derivative 20,000 $0.00 Strike: $28.40 $0.00
Disclosure

SEC source: 0000875320-08-000037 · edgar.xml · derivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2018-05-31

F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested.

Read SEC document
June 01, 2008 Filed Jun 2, 2008 20:43 UTC
BRANDT ERICDirector
GrantStock Option · Derivative 20,000 $0.00 Strike: $28.40 $0.00
Disclosure

SEC source: 0000875320-08-000038 · edgar.xml · derivative · entry 1

BRANDT ERIC · CIK 0001190639 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2018-05-31

F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested.

Read SEC document
June 01, 2008 Filed Jun 2, 2008 20:45 UTC GrantStock Option · Derivative 20,000 $0.00 Strike: $28.40 $0.00
Disclosure

SEC source: 0000875320-08-000039 · edgar.xml · derivative · entry 1

COLLINSON STUART J · CIK 0001197037 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2018-05-31

F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested.

Read SEC document
June 01, 2008 Filed Jun 2, 2008 20:46 UTC GrantStock Option · Derivative 20,000 $0.00 Strike: $28.40 $0.00
Disclosure

SEC source: 0000875320-08-000040 · edgar.xml · derivative · entry 1

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2018-05-31

F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested.

Read SEC document
June 01, 2008 Filed Jun 2, 2008 20:49 UTC GrantStock Option · Derivative 20,000 $0.00 Strike: $28.40 $0.00
Disclosure

SEC source: 0000875320-08-000041 · edgar.xml · derivative · entry 1

Emmens Matthew · CIK 0001298332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2018-05-31

F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested.

Read SEC document
June 01, 2008 Filed Jun 2, 2008 20:50 UTC GrantStock Option · Derivative 20,000 $0.00 Strike: $28.40 $0.00
Disclosure

SEC source: 0000875320-08-000042 · edgar.xml · derivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2018-05-31

F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC GrantStock Option · Derivative 3,333 $0.00 Strike: $14.20 $0.00
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · derivative · entry 11

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,333 shares

Expires 2008-05-31

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1998.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC SaleCommon Stock 333 $27.16 $9,044.28
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · nonDerivative · entry 10

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,383

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC SaleCommon Stock 333 $26.99 $8,987.67
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · nonDerivative · entry 9

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,716

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC SaleCommon Stock 334 $26.84 $8,964.56
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · nonDerivative · entry 8

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,049

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC SaleCommon Stock 333 $26.75 $8,907.75
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · nonDerivative · entry 7

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,383

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC SaleCommon Stock 333 $26.71 $8,894.43
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · nonDerivative · entry 6

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,716

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC SaleCommon Stock 666 $26.68 $17,768.88
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · nonDerivative · entry 5

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,049

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC SaleCommon Stock 334 $26.66 $8,904.44
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · nonDerivative · entry 4

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,715

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC SaleCommon Stock 334 $26.54 $8,864.36
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · nonDerivative · entry 3

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,049

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC SaleCommon Stock 333 $26.40 $8,791.20
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · nonDerivative · entry 2

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,383

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:55 UTC Exercise / conversionCommon Stock 3,333 $14.20 $47,328.60
Disclosure

SEC source: 0000875320-08-000033 · edgar.xml · nonDerivative · entry 1

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC GrantStock Option · Derivative 3,333 $0.00 Strike: $14.20 $0.00
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · derivative · entry 11

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,333 shares

Expires 2008-05-31

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1998.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC SaleCommon Stock 333 $27.16 $9,044.28
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · nonDerivative · entry 10

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC SaleCommon Stock 333 $26.99 $8,987.67
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · nonDerivative · entry 9

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC SaleCommon Stock 334 $26.84 $8,964.56
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · nonDerivative · entry 8

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 666

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC SaleCommon Stock 333 $26.75 $8,907.75
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · nonDerivative · entry 7

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC SaleCommon Stock 333 $26.71 $8,894.43
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · nonDerivative · entry 6

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,333

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC SaleCommon Stock 666 $26.68 $17,768.88
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · nonDerivative · entry 5

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,666

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC SaleCommon Stock 334 $26.66 $8,904.44
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · nonDerivative · entry 4

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,332

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC SaleCommon Stock 334 $26.54 $8,864.36
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · nonDerivative · entry 3

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,666

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC SaleCommon Stock 333 $26.40 $8,791.20
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · nonDerivative · entry 2

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 27, 2008 Filed May 28, 2008 17:58 UTC Exercise / conversionCommon Stock 3,333 $14.20 $47,328.60
Disclosure

SEC source: 0000875320-08-000034 · edgar.xml · nonDerivative · entry 1

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2008 Filed May 22, 2008 13:24 UTC
ALAM JOHN JEVP, Med. Dev. Group & CMO
SaleCommon Stock 80 $27.89 $2,231.20
Disclosure

SEC source: 0000875320-08-000029 · edgar.xml · nonDerivative · entry 8

ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,511

F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC GrantStock Option · Derivative 3,333 $0.00 Strike: $14.20 $0.00
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · derivative · entry 11

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,333

Underlying: Common Stock · 3,333 shares

Expires 2008-05-31

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1998.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC SaleCommon Stock 333 $27.67 $9,214.11
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · nonDerivative · entry 10

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,383

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC SaleCommon Stock 334 $27.47 $9,174.98
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · nonDerivative · entry 9

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,716

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC SaleCommon Stock 333 $27.46 $9,144.18
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · nonDerivative · entry 8

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,050

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC SaleCommon Stock 333 $27.73 $9,234.09
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · nonDerivative · entry 7

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,383

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC SaleCommon Stock 667 $27.71 $18,482.57
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · nonDerivative · entry 6

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,716

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC SaleCommon Stock 333 $27.61 $9,194.13
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · nonDerivative · entry 5

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,383

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC SaleCommon Stock 333 $27.59 $9,187.47
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · nonDerivative · entry 4

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,716

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC SaleCommon Stock 333 $27.58 $9,184.14
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · nonDerivative · entry 3

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,049

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC SaleCommon Stock 334 $27.50 $9,185.00
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · nonDerivative · entry 2

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,382

F1 · kind: Transaction made pursuant to Dr. Sanders' company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:36 UTC Exercise / conversionCommon Stock 3,333 $14.20 $47,328.60
Disclosure

SEC source: 0000875320-08-000027 · edgar.xml · nonDerivative · entry 1

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:38 UTC GrantStock Option · Derivative 3,333 $0.00 Strike: $14.20 $0.00
Disclosure

SEC source: 0000875320-08-000028 · edgar.xml · derivative · entry 10

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,333

Underlying: Common Stock · 3,333 shares

Expires 2008-05-31

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1998.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:38 UTC SaleCommon Stock 333 $27.68 $9,217.44
Disclosure

SEC source: 0000875320-08-000028 · edgar.xml · nonDerivative · entry 9

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:38 UTC SaleCommon Stock 667 $27.47 $18,322.49
Disclosure

SEC source: 0000875320-08-000028 · edgar.xml · nonDerivative · entry 8

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:38 UTC SaleCommon Stock 333 $27.73 $9,234.09
Disclosure

SEC source: 0000875320-08-000028 · edgar.xml · nonDerivative · entry 7

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:38 UTC SaleCommon Stock 667 $27.71 $18,482.57
Disclosure

SEC source: 0000875320-08-000028 · edgar.xml · nonDerivative · entry 6

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,333

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:38 UTC SaleCommon Stock 333 $27.61 $9,194.13
Disclosure

SEC source: 0000875320-08-000028 · edgar.xml · nonDerivative · entry 5

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:38 UTC SaleCommon Stock 333 $27.59 $9,187.47
Disclosure

SEC source: 0000875320-08-000028 · edgar.xml · nonDerivative · entry 4

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,333

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:38 UTC SaleCommon Stock 333 $27.58 $9,184.14
Disclosure

SEC source: 0000875320-08-000028 · edgar.xml · nonDerivative · entry 3

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,666

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:38 UTC SaleCommon Stock 334 $27.50 $9,185.00
Disclosure

SEC source: 0000875320-08-000028 · edgar.xml · nonDerivative · entry 2

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,999

F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.

Read SEC document
May 20, 2008 Filed May 21, 2008 19:38 UTC Exercise / conversionCommon Stock 3,333 $14.20 $47,328.60
Disclosure

SEC source: 0000875320-08-000028 · edgar.xml · nonDerivative · entry 1

BRIMBLECOMBE ROGER W · CIK 0001197034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.